the projected 3-year probability of leukemia-free survival ( lfs ) was 56 % ( 95 % ci , 35 % to 77 % ) after transplantation for aml-cr1 , 42 % ( 95 % ci , 16 % to 69 % ) in patients transplanted for all-cr1 , and 49 % ( 95 % ci , 18 % to 80 % ) after transplantation for cml-cp1 .
C0023418
free
C0023467
aml